8/19/24 08:25  | 8/16/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Bigal Marcelo | FL | D |  | P | 20 | 13.25 | 0 | 2 | 18 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/19/24 08:25  | 8/16/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Brege Laura | FL | D |  | P | 13 | 12.81 | 0 | 1 | 6 | 18 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/14/24 16:35  | 8/14/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Yang Michael J. | FL | D |  | P | 26 | 12.90 | 0 | 2 | 38 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/13/24 16:55  | 8/12/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Lee Frank D. | FL | DO | CEO | P | 100 | 12.10 | 0 | 8 | 8 | 108 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/13/24 08:43  | 8/12/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Bigal Marcelo | FL | D |  | P.a | 41 | 12.01 | 0 | 3 | 65 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/24 20:33  | 8/12/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Froimson Mark | FL | D |  | P | 16 | 11.58 | 0 | 1 | 11 | 14 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/24 20:33  | 8/12/24  | PCRX | Health | Drug | Pharmaceutical Preparations | Bigal Marcelo | FL | D |  | P | 41 | 12.01 | 0 | 3 | 65 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/12/20 19:18  | 3/11/20  | PCRX | Health | Drug | Pharmaceutical Preparations | Winston Roy | NJ | O | Chief Cl | P | 91 | 36.50 | 0 | 3 | 11 | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/8/19 16:17  | 3/6/19  | PCRX | Health | Drug | Pharmaceutical Preparations | Kronenfeld Mark A. | NJ | D |  | P | 66 | 38.97 | 0 | 2 | 20 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/21/18 16:07  | 11/19/18  | PCRX | Health | Drug | Pharmaceutical Preparations | Pace Gary W | NJ | D |  | P | 208 | 46.18 | 0 | 5 | 16 | 33 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/9/18 16:30  | 11/7/18  | PCRX | Health | Drug | Pharmaceutical Preparations | Pace Gary W | NJ | D |  | P | 205 | 51.29 | 0 | 4 | 16 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/30/18 16:34  | 8/28/18  | PCRX | Health | Drug | Pharmaceutical Preparations | Kronenfeld Mark A. | NJ | D |  | P | 45 | 44.61 | 0 | 1 | 13 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/13/17 20:03  | 11/10/17  | PCRX | Health | Drug | Pharmaceutical Preparations | Kronenfeld Mark A. | NJ | D |  | P | 42 | 41.60 | 0 | 1 | 17 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/16/17 20:43  | 8/8/17  | PCRX | Health | Drug | Pharmaceutical Preparations | Froimson Mark | NJ | D |  | P | 4 | 37.13 | 0 | 0 | New | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/1/16 19:27  | 1/29/16  | PCRX | Health | Drug | Pharmaceutical Preparations | Braunstein Scott | NJ | O | SVP,Stra | P | 118 | 58.92 | 33 | 2 | New | 2 | D | -4 | -46 | -4 | 17 | -19 | -12 | -13 | -9 | -4 | -1 | -21 | -16 | -46 | -46 | 
1/29/16 18:45  | 1/27/16  | PCRX | Health | Drug | Pharmaceutical Preparations | Jones James B | NJ | O | SVP,Chie | P | 31 | 62.50 | 33 | 1 | 50 | 2 | D | -11 | -43 | -2 | 17 | -19 | -15 | -14 | -12 | 7 | 8 | -13 | -7 | -38 | -39 | 
1/14/16 19:37  | 1/12/16  | PCRX | Health | Drug | Pharmaceutical Preparations | Longenecker John P Phd | NJ | D |  | P | 20 | 66.55 | 33 | 0 | 15 | 2 | D | -4 | -36 | -8 | 66 | -8 | -19 | -19 | -9 | 3 | -1 | -14 | -2 | -48 | -42 | 
1/14/16 19:36  | 1/12/16  | PCRX | Health | Drug | Pharmaceutical Preparations | Jones James B | NJ | O | SVP,Chie | P | 66 | 66.00 | 33 | 1 | New | 1 | D | -4 | -36 | -8 | 66 | -8 | -19 | -19 | -9 | 3 | -1 | -14 | -2 | -48 | -42 | 
9/14/15 17:59  | 9/11/15  | PCRX | Health | Drug | Pharmaceutical Preparations | Scibetta James S | NJ | O | SVP,CFO | P | 307 | 61.37 | 33 | 5 | 91 | 11 | D | 69 | -39 | -32 | -21 | -6 | 5 | 12 | 9 | 5 | 5 | -38 | 0 | -15 | -37 | 
3/17/15 20:06  | 3/13/15  | PCRX | Health | Drug | Pharmaceutical Preparations | Pace Gary W | NJ | D |  | P | 94 | 93.83 | 33 | 1 | 6 | 19 | D | 224 | 36 | -7 | 4 | -11 | -16 | -1 | 5 | 2 | -1 | -4 | -18 | -33 | -47 | 
12/8/14 19:29  | 12/5/14  | PCRX | Health | Drug | Pharmaceutical Preparations | Winger Dennis L | NJ | D |  | P | 250 | 94.54 | 33 | 3 | New | 3 | D | 471 | 80 | 12 | -9 | -11 | 7 | 0 | 3 | 2 | -2 | -5 | -1 | -17 | -33 | 
11/12/14 19:56  | 11/7/14  | PCRX | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | SVP,Chie | P | 20 | 86.62 | 33 | 0 | New | 0 | I | 455 | 68 | 17 | -16 | -9 | -14 | -6 | -4 | -1 | 2 | 4 | 29 | -14 | -40 | 
11/4/14 19:42  | 11/3/14  | PCRX | Health | Drug | Pharmaceutical Preparations | Kronenfeld Mark A. | NJ | D |  | P | 77 | 90.48 | 33 | 1 | 85 | 2 | D | 475 | 77 | 24 | -6 | -10 | -8 | -12 | -14 | -3 | -2 | 6 | 18 | -23 | -38 | 
9/13/13 19:26  | 9/11/13  | PCRX | Health | Drug | Pharmaceutical Preparations | Kronenfeld Mark A. | NJ | D |  | P | 37 | 37.01 | 7 | 1 | New | 1 | D | 359 | 113 | 27 | 26 | 12 | 4 | 3 | 3 | 3 | 4 | 35 | 26 | 83 | 169 | 
5/17/13 18:02  | 5/15/13  | PCRX | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | D |  | P | 25 | 29.30 | 11 | 1 | New | 1 | D | 184 | 172 | 80 | 48 | 3 | 4 | 8 | 0 | -3 | 1 | 1 | 23 | 86 | 157 | 
4/17/12 17:24  | 4/17/12  | PCRX | Health | Drug | Pharmaceutical Preparations | Pace Gary W | CA | D |  | P | 98 | 9.75 | 3 | 10 | 130 | 18 | D |  | 40 | -3 | 22 | -8 | -16 | -9 | -4 | 1 | 1 | 8 | 58 | 82 | 185 | 
11/23/11 18:09  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Middleton Fred A | CA | DT |  | P | 65 | 6.50 | 5 | 10 | 0 | 2,932 | D |  |  | -51 | -15 | -24 | -9 | 3 | 2 | -4 | -1 | 12 | 44 | 47 | 118 | 
11/23/11 18:09  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Pace Gary W | CA | D |  | P | 50 | 6.50 | 5 | 8 | New | 8 | D |  |  | -51 | -15 | -24 | -9 | 3 | 2 | -4 | -1 | 12 | 44 | 47 | 118 | 
11/22/11 18:48  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures Cayman Ltd |  | T |  | P | 2,000 | 6.50 | 5 | 308 | 10 | 3,445 | D |  |  | -47 | -18 | -25 | -20 | 1 | -1 | -1 | -6 | 12 | 42 | 45 | 119 | 
11/22/11 18:46  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Wicki Andreas |  | D |  | P | 2,000 | 6.50 | 5 | 308 | 10 | 3,445 | I |  |  | -47 | -18 | -25 | -20 | 1 | -1 | -1 | -6 | 12 | 42 | 45 | 119 | 
11/22/11 14:04  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures IV Qp LP | MA | T |  | P | 3,000 | 6.50 | 5 | 462 | 16 | 3,290 | I |  |  | -47 | -18 | -25 | -20 | 1 | -1 | 2 | -4 | 14 | 44 | 47 | 121 | 
11/22/11 14:00  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Kailian Vaughn M | MA | T |  | P | 3,000 | 6.50 | 5 | 462 | 16 | 3,290 | I |  |  | -47 | -18 | -25 | -20 | 1 | -1 | 2 | -4 | 14 | 44 | 47 | 121 | 
11/22/11 13:58  | 11/21/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Evnin Luke | MA | DT |  | P | 3,000 | 6.50 | 5 | 462 | 16 | 3,290 | I |  |  | -47 | -18 | -25 | -20 | 1 | -1 | 2 | -4 | 14 | 44 | 47 | 121 | 
2/17/11 14:58  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures IV Qp LP | MA | T |  | P.ad | 3,750 | 7.00 | 2 | 536 | 23 | 2,829 | I |  |  |  |  |  |  | -7 | -5 | 6 | 5 | 6 | 61 | 40 | 55 | 
2/17/11 14:57  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Evnin Luke | MA | DT |  | P.ad | 3,750 | 7.00 | 2 | 536 | 23 | 2,829 | I |  |  |  |  |  |  | -7 | -5 | 6 | 5 | 6 | 61 | 40 | 55 | 
2/17/11 14:55  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Kailian Vaughn M | MA | T |  | P.ad | 3,750 | 7.00 | 2 | 536 | 23 | 2,829 | I |  |  |  |  |  |  | -7 | -5 | 6 | 5 | 6 | 61 | 40 | 55 | 
2/16/11 18:53  | 2/15/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Scibetta James S | CA | O | CFO | P | 35 | 7.04 | 2 | 5 | New | 5 | D |  |  |  |  |  |  | -2 | 4 | 5 | 5 | 7 | 56 | 35 | 57 | 
2/11/11 15:29  | 2/10/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Stack David M | CA | DO | P,CEO | P | 33 | 6.60 | 3 | 5 | 27 | 24 | D |  |  |  |  |  |  |  | -6 | 4 | 4 | 3 | 60 | 36 | 55 | 
2/10/11 21:55  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Sanderling Venture Partners VI LP | CA | T |  | P | 1,550 | 7.00 | 3 | 221 |  | 184 | D |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 21:55  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Sanderling Venture Partners VI LP | CA | T |  | P.d | 325 | 7.00 | 3 | 46 | New | 46 | D |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 20:36  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Wicki Andreas |  | D |  | P.d | 3,750 | 7.00 | 3 | 536 | 21 | 3,138 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 20:35  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures Cayman Ltd |  | T |  | P.d | 3,750 | 7.00 | 3 | 536 | 21 | 3,138 | D |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 20:06  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Middleton Fred A | CA | D |  | P.d | 1,875 | 7.00 | 3 | 268 |  | 184 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 18:47  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | NY | D |  | P.d | 3,750 | 7.00 | 3 | 536 | 23 | 2,829 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 18:47  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | T |  | P.d | 3,750 | 7.00 | 3 | 536 | 10 | 5,655 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 16:27  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures IV Qp LP | MA | T |  | P.ed | 3,750 | 7.00 | 3 | 536 | 23 | 2,829 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 16:21  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Evnin Luke | MA | DT |  | P.ed | 3,750 | 7.00 | 3 | 536 | 23 | 2,829 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 | 
2/10/11 16:18  | 2/8/11  | PCRX | Health | Drug | Pharmaceutical Preparations | Kailian Vaughn M | MA | T |  | P.ed | 3,750 | 7.00 | 3 | 536 | 23 | 2,829 | I |  |  |  |  |  |  |  | -11 | 4 | -1 | 4 | 59 | 35 | 60 |